E. Kuntz Richard's Insider Trades & SAST Disclosures
E. Kuntz Richard's most recent trade in ZimVie Inc was a trade of 21,119 Restricted Stock Units done . Disclosure was reported to the exchange on May 7, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern E. Kuntz Richard.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 21,119 | 57,728 | - | - | Restricted Stock Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 500 | 11,069 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,163 | 10,569 | - | - | Deferred Share Units | |
| DiaMedica Therapeutics Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 5.34 per share. | 02 Jan 2025 | 9,925 | 24,210 (0%) | 0% | 5.3 | 53,000 | Voting Common Shares, no par value per share |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 894 | 9,406 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 795 | 8,511 | - | - | Deferred Share Units | |
| Identiv Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jul 2024 | 14,773 | 27,020 (0%) | 0% | 0 | Common Stock | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 696 | 7,716 | - | - | Deferred Share Units | |
| DiaMedica Therapeutics Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 28,472 | 28,472 | - | - | Stock Option (right to buy) | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 11,012 | 36,609 | - | - | Restricted Stock Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 500 | 7,019 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 764 | 6,519 | - | - | Deferred Share Units | |
| DiaMedica Therapeutics Inc | E. Kuntz Richard | Director | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 02 Jan 2024 | 14,285 | 14,285 (0%) | 0% | 2.8 | 39,998 | Voting Common Shares, no par value per share |
| Identiv Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 8,904 | 12,247 (0%) | 0% | 0 | Common Stock | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 762 | 5,755 | - | - | Deferred Share Units | |
| DiaMedica Therapeutics Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 May 2023 | 32,320 | 32,320 | - | - | Stock option (right to buy) | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 17,704 | 25,597 | - | - | Restricted Stock Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2023 | 500 | 4,993 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 1,241 | 4,493 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 957 | 3,251 | - | - | Deferred Share Units | |
| Identiv Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Oct 2022 | 3,343 | 3,343 (0%) | 0% | 0 | Common Stock | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 870 | 2,294 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 541 | 1,423 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 7,893 | 7,893 | - | - | Restricted Stock Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 500 | 882 | - | - | Deferred Share Units | |
| ZimVie Inc | Richard E. Kuntz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 382 | 382 | - | - | Deferred Share Units | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 122.98 per share. | 05 Nov 2021 | 209 | 74,945 (0%) | 0% | 123.0 | 25,703 | Ordinary Shares |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 42,961 | 42,961 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 12,571 | 12,571 | - | - | Performance Share Units | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 5,029 | 74,915 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.31 per share. | 02 Aug 2021 | 4,905 | 69,886 (0%) | 0% | 131.3 | 644,076 | Ordinary Shares |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 1,085 | 1,085 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 103.13 per share. | 03 Nov 2020 | 273 | 74,009 (0%) | 0% | 103.1 | 28,154 | Ordinary Shares |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 14,723 | 14,723 | - | - | Performance Share Units | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 60,453 | 60,453 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 36,524 | 36,524 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 6,576 | 74,001 (0%) | 0% | 0 | Ordinary Shares | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2020 | 1,575 | 1,575 | - | - | Stock Option (Right to Buy) | |
| Medtronic Plc | Richard E. Kuntz | SVP & Chief Medical & Science | Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.48 per share. | 31 Jul 2020 | 4,482 | 67,425 (0%) | 0% | 96.5 | 432,423 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges